Frontlight ResearchEarly access
Bladder cancer trials in Puerto Rico
3 of 5 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Where
- San Juan
- Age
- 18 years and over
- People
- 314 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03866382 - Phase 1Taking peopleA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Where
- Rio Piedras
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Pfizer
See details and how to joinNCT07090499 · EU 2025-521729-33-00 - Phase 1/2Taking peopleSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Where
- Manati, Mayagüez, Rio Piedras
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Pfizer
See details and how to joinNCT07421700 · EU 2025-523523-21-00